Investment Management, 8VantEdge

8VantEdge

Investment Management

8VantEdge offers a hybrid fundamental stock picking combined with algorithmic rules based on human psychology.

Thematic (Sector/Industry)

<ul>
<li>Singapore’s healthcare and life sciences sector presents a compelling structural growth opportunity in 2026. In our view, two complementary engines underpin the sector’s long term expansion narrative: biomedical manufacturing and clinical services.</li>
<li>Biomedical manufacturing provides scale and export opportunities. Multinational corporations and homegrown enterprises leverage Singapore's proactive regulatory framework, secure data architectures, and advanced infrastructure to produce high-value medical devices and novel therapeutics.</li>
<li>Clinical services, on the other hand, scales through tech-enabled primary care networks, specialist hospitals, and regional expansion targeting rising Asian healthcare demand. The sector is increasingly shifting away from traditional hospital-centric models toward decentralized care, supported by telemedicine, home monitoring and integrated community care.</li>
</ul>


Singapore’s healthcare and life sciences sector presents a compelling structural growth opportunity in 2026. In our view, two complementary engines underpin the sector’s long term expansion narrative: biomedical manufacturing and clinical services.
Biomedical manufacturing provides scale and export opportunities. Multinational corporations and homegrown enterprises leverage Singapore's proactive regulatory framework, secure data architectures, and advanced infrastructure to produce high-value medical devices and novel therapeutics.
Clinical services, on the other hand, scales through tech-enabled primary care networks, specialist hospitals, and regional expansion targeting rising Asian healthcare demand. The sector is increasingly shifting away from traditional hospital-centric models toward decentralized care, supported by telemedicine, home monitoring and integrated community care.


Health Horizons: Singapore's Rising Stars in Biotech & Medtech

Singapore Market Roundup, Singapore Market Roundup

Singapore Market Roundup

<ul><li>CGSI flags lower earnings for Riverstone due to currency shifts, maintains 'add' rating.</li><li>17Live's challenges might be easing, according to Lim &amp; Tan's report.</li><li>DBS suggests parent company could increase dividends from Genting Singapore.</li></ul>

CGSI flags lower earnings for Riverstone due to currency shifts, maintains 'add' rating.17Live's challenges might be easing, according to Lim &amp; Tan's report.DBS suggests parent company could increase dividends from Genting Singapore.

Singapore Market Roundup (14-Oct-2025): CGSI lowers Riverstone earnings forecast, keeps 'add'

<ul><li>Wilmar International may have passed its worst phase.</li><li>RHB downgrades Keppel REIT to neutral following Australian retail acquisition news.</li><li>OCBC: ST Engineering's growth is intact, but its risk-reward is now balanced.</li></ul>

Wilmar International may have passed its worst phase.RHB downgrades Keppel REIT to neutral following Australian retail acquisition news.OCBC: ST Engineering's growth is intact, but its risk-reward is now balanced.

Singapore Market Roundup (09-Oct-2025): Wilmar International may have overcome its toughest times.

External reports (aggregated public sources), Value Investors Club

Value Investors Club (VIC)

External reports (aggregated public sources)

Value Investors Club

Equity Bottom-Up

<ul><li>RSE repurchased 30% of outstanding shares in 2022, boosting NAV per share</li><li>RSE's focus on energy transition and decarbonization makes it an attractive long-term investment</li><li>Stock's current discount to NAV and structural challenges present growth opportunities for investors willing to bet on its potential</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

RSE repurchased 30% of outstanding shares in 2022, boosting NAV per shareRSE's focus on energy transition and decarbonization makes it an attractive long-term investmentStock's current discount to NAV and structural challenges present growth opportunities for investors willing to bet on its potentialThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Riverstone Energy Ltd (RSE LN) - Wednesday, May 29, 2024

SGX Market Strategist, Equity & Fixed Income, Singapore Exchange Ltd (SGX)

Geoff Howie

SGX Market Strategist, Equity & Fixed Income

Asia’s leading multi-asset exchange

Singapore Exchange Ltd (SGX)

Singapore Exchange is Asia’s leading and trusted market infrastructure, facilitating the exchange of capital and ideas to create value for people, businesses and economies. As a multi-asset exchange operating equity, fixed income and derivatives markets to the highest regulatory standards, SGX is a vertically integrated business that provides listing, trading, clearing, settlement, depository and data services.

With about 40% of listed companies and over 80% of listed bonds originating outside of Singapore as well as established linkages across the region and in Europe, SGX is Asia’s most international and connected exchange. Offering a full suite of derivatives products across Asian equity indices, commodities and currencies, SGX is the world’s most liquid international market for the benchmark equity indices of China, India, Japan and ASEAN.

As Asia’s pioneering central counterparty, SGX is globally recognised for its risk management and clearing capabilities, and was one of the first globally to adopt the Principles for Financial Market Infrastructure.

Headquartered in AAA-rated Singapore, SGX has over 800 employees including offices in Beijing, Chicago, Hong Kong, London, New York, Mumbai, San Francisco, Shanghai and Tokyo.

<ul><li>From the end of 2019 to 9 Jan 2023, the iEdge SG Adv Manufacturing Index generated a 21% total return.</li><li>Four of the 10 - Yangzijiang Shipbuilding, Dyna-Mac, Halcyon Agri Corp and Sembcorp Marine were among the strongest seven strongest performers of the Index in 2022, with micro-caps Acesian Partners, Global Testing Corp, XMH Holdings the three strongest Index performers for the year.</li><li>Since 2019, the iEdge SG Advanced Manufacturing Index has generated a 21% total return which is close to the mid-point of the gains booked by global Industrial and Technology stocks since 2019.</li></ul>

From the end of 2019 to 9 Jan 2023, the iEdge SG Adv Manufacturing Index generated a 21% total return.Four of the 10 - Yangzijiang Shipbuilding, Dyna-Mac, Halcyon Agri Corp and Sembcorp Marine were among the strongest seven strongest performers of the Index in 2022, with micro-caps Acesian Partners, Global Testing Corp, XMH Holdings the three strongest Index performers for the year.Since 2019, the iEdge SG Advanced Manufacturing Index has generated a 21% total return which is close to the mid-point of the gains booked by global Industrial and Technology stocks since 2019.

Singapore Manufacturing Index Books 21% Total Return since 2019 

Singapore

Riverstone Holdings Limited is a manufacturer and distributor of cleanroom and healthcare products, including nitrile gloves, finger cots, face masks, and packaging bags. The company serves the hard disk drive, semiconductor, and healthcare industries. Headquartered in Singapore, the company was established in 1989.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Riverstone (RSTON SP)

Health Horizons: Singapore's Rising Stars in Biotech & Medtech

Singapore’s healthcare and life sciences sector presents a compelling structural growth opportunity in 2026. In our view, two complementary...

8VantEdge

Singapore Market Roundup (14-Oct-2025): CGSI lowers Riverstone earnings forecast, keeps 'add'

CGSI lowers earnings outlook for Riverstone amid currency shifts but keeps 'add' rating. 17Live's issues may be improving, while DBS hints at...

Singapore Market Roundup

Singapore Market Roundup (09-Oct-2025): Wilmar International may have overcome its toughest times.

Wilmar International may have improved, while RHB downgrades Keppel REIT to neutral after its Australian acquisition. OCBC sees ST Engineering's...

Singapore Market Roundup

Riverstone Energy Ltd (RSE LN) - Wednesday, May 29, 2024

RSE repurchased 30% of outstanding shares in 2022, boosting NAV per share. RSE's focus on energy transition and decarbonization makes it an...

Value Investors Club (VIC)

Singapore Manufacturing Index Books 21% Total Return since 2019

From the end of 2019 to 9 Jan 2023, the iEdge SG Adv Manufacturing Index generated a 21% total return. Four of the 10 - Yangzijiang Shipbuilding,...

Singapore Exchange Ltd (SGX)

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)